Back to Search
Start Over
Tizona Announces Publication in Cancer Discovery Highlighting the Important Role of CD39 and Extracellular ATP in Inflammasome-driven Anti-Tumor Immunity
- Source :
- Plus Company Updates. November 8, 2019
- Publication Year :
- 2019
-
Abstract
- SOUTH SAN FRANCISCO: Tizona Therapeutics, Inc. has issued the following press release: Tizona Therapeutics, Inc., a clinical stage, privately held company developing first-in-class cancer immunotherapies, announced today the online publication [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.605286311